Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Karen Ballen, Md

Clinical trials sponsored by Karen Ballen, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Targeted drug aims to stop blood cancer return after transplant Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Targeted drug aims to stop blood cancer return after transplant

Disease control Ongoing

This phase 1 trial tests whether the drug tagraxofusp can help prevent relapse in people with certain blood cancers (acute myeloid leukemia, myelodysplastic syndrome, myelofibrosis, or chronic myelomonocytic leukemia) who have recently received a stem cell transplant. Participant…

Phase 1 • Sponsor: Karen Ballen, MD • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC